266 related articles for article (PubMed ID: 26411365)
1. Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism.
Sartorius CA; Hanna CT; Gril B; Cruz H; Serkova NJ; Huber KM; Kabos P; Schedin TB; Borges VF; Steeg PS; Cittelly DM
Oncogene; 2016 Jun; 35(22):2881-92. PubMed ID: 26411365
[TBL] [Abstract][Full Text] [Related]
2. Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.
Contreras-Zárate MJ; Day NL; Ormond DR; Borges VF; Tobet S; Gril B; Steeg PS; Cittelly DM
Oncogene; 2019 Jun; 38(24):4685-4699. PubMed ID: 30796353
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of estrogen-dependent transactivation vs. transrepression by the estrogen receptor on invasiveness of HER2 overexpressing breast cancer cells.
Patki M; Salazar Md; Trumbly R; Ratnam M
Biochem Biophys Res Commun; 2015 Feb; 457(3):404-11. PubMed ID: 25582774
[TBL] [Abstract][Full Text] [Related]
4. Astrocyte-induced Reelin expression drives proliferation of Her2
Jandial R; Choy C; Levy DM; Chen MY; Ansari KI
Clin Exp Metastasis; 2017 Feb; 34(2):185-196. PubMed ID: 28210910
[TBL] [Abstract][Full Text] [Related]
5. A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells.
Zhang XT; Kang LG; Ding L; Vranic S; Gatalica Z; Wang ZY
Oncogene; 2011 Feb; 30(7):770-80. PubMed ID: 20935677
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen suppresses brain metastasis of estrogen receptor-deficient breast cancer by skewing microglia polarization and enhancing their immune functions.
Wu SY; Sharma S; Wu K; Tyagi A; Zhao D; Deshpande RP; Watabe K
Breast Cancer Res; 2021 Mar; 23(1):35. PubMed ID: 33736709
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade.
Martin JL; de Silva HC; Lin MZ; Scott CD; Baxter RC
Mol Cancer Ther; 2014 Feb; 13(2):316-28. PubMed ID: 24337110
[TBL] [Abstract][Full Text] [Related]
8. Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer.
Ren D; Zhu X; Kong R; Zhao Z; Sheng J; Wang J; Xu X; Liu J; Cui K; Zhang XH; Zhao H; Wong STC
Cancer Res; 2018 Apr; 78(8):2052-2064. PubMed ID: 29567857
[TBL] [Abstract][Full Text] [Related]
9. Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases.
Contreras-Zárate MJ; Ormond DR; Gillen AE; Hanna C; Day NL; Serkova NJ; Jacobsen BM; Edgerton SM; Thor AD; Borges VF; Lillehei KO; Graner MW; Kabos P; Cittelly DM
Front Oncol; 2017; 7():252. PubMed ID: 29164052
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade.
Choy C; Raytis JL; Smith DD; Duenas M; Neman J; Jandial R; Lew MW
Oncol Rep; 2016 Jun; 35(6):3135-42. PubMed ID: 27035124
[TBL] [Abstract][Full Text] [Related]
11. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.
Han R; Gu S; Zhang Y; Luo A; Jing X; Zhao L; Zhao X; Zhang L
Sci Rep; 2018 Jun; 8(1):9575. PubMed ID: 29934505
[TBL] [Abstract][Full Text] [Related]
12. Astrocytic IGFBP2 and CHI3L1 in cerebrospinal fluid drive cortical metastasis of HER2+breast cancer.
Ansari KI; Bhan A; Liu X; Chen MY; Jandial R
Clin Exp Metastasis; 2020 Jun; 37(3):401-412. PubMed ID: 32279122
[TBL] [Abstract][Full Text] [Related]
13. Pazopanib inhibits the activation of PDGFRβ-expressing astrocytes in the brain metastatic microenvironment of breast cancer cells.
Gril B; Palmieri D; Qian Y; Anwar T; Liewehr DJ; Steinberg SM; Andreu Z; Masana D; Fernández P; Steeg PS; Vidal-Vanaclocha F
Am J Pathol; 2013 Jun; 182(6):2368-79. PubMed ID: 23583652
[TBL] [Abstract][Full Text] [Related]
14. Arsenic Attenuates Heparin-Binding EGF-Like Growth Factor/EGFR Signaling That Promotes Matrix Metalloprotease 9-Dependent Astrocyte Damage in the Developing Rat Brain.
Kushwaha R; Mishra J; Tripathi S; Raza W; Mandrah K; Roy SK; Bandyopadhyay S
Toxicol Sci; 2018 Apr; 162(2):406-428. PubMed ID: 29228391
[TBL] [Abstract][Full Text] [Related]
15. PTEN mediates the cross talk between breast and glial cells in brain metastases leading to rapid disease progression.
Hohensee I; Chuang HN; Grottke A; Werner S; Schulte A; Horn S; Lamszus K; Bartkowiak K; Witzel I; Westphal M; Matschke J; Glatzel M; Jücker M; Pukrop T; Pantel K; Wikman H
Oncotarget; 2017 Jan; 8(4):6155-6168. PubMed ID: 28008153
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis.
Shen Q; Sahin AA; Hess KR; Suki D; Aldape KD; Sawaya R; Ibrahim NK
Oncologist; 2015 May; 20(5):466-73. PubMed ID: 25802405
[TBL] [Abstract][Full Text] [Related]
17. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
Ogba N; Manning NG; Bliesner BS; Ambler SK; Haughian JM; Pinto MP; Jedlicka P; Joensuu K; Heikkilä P; Horwitz KB
Breast Cancer Res; 2014 Dec; 16(6):489. PubMed ID: 25475897
[TBL] [Abstract][Full Text] [Related]
18. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53.
Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY
World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035
[TBL] [Abstract][Full Text] [Related]
19. Cypermethrin induces astrocyte apoptosis by the disruption of the autocrine/paracrine mode of epidermal growth factor receptor signaling.
Maurya SK; Rai A; Rai NK; Deshpande S; Jain R; Mudiam MK; Prabhakar YS; Bandyopadhyay S
Toxicol Sci; 2012 Feb; 125(2):473-87. PubMed ID: 22048644
[TBL] [Abstract][Full Text] [Related]
20. Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer.
Darlix A; Griguolo G; Thezenas S; Kantelhardt E; Thomssen C; Dieci MV; Miglietta F; Conte P; Braccini AL; Ferrero JM; Bailleux C; Jacot W; Guarneri V
J Neurooncol; 2018 Jun; 138(2):369-382. PubMed ID: 29488184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
